BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22589192)

  • 21. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
    Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxiredoxin 6 homodimerization and heterodimerization with glutathione S-transferase pi are required for its peroxidase but not phospholipase A2 activity.
    Zhou S; Sorokina EM; Harper S; Li H; Ralat L; Dodia C; Speicher DW; Feinstein SI; Fisher AB
    Free Radic Biol Med; 2016 May; 94():145-56. PubMed ID: 26891882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-translational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE.
    Stephens AN; Hannan NJ; Rainczuk A; Meehan KL; Chen J; Nicholls PK; Rombauts LJ; Stanton PG; Robertson DM; Salamonsen LA
    J Proteome Res; 2010 May; 9(5):2438-49. PubMed ID: 20199104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of diagonal chromatography for proteome-wide characterization of protein modifications and activity-based analyses.
    Gevaert K; Impens F; Van Damme P; Ghesquière B; Hanoulle X; Vandekerckhove J
    FEBS J; 2007 Dec; 274(24):6277-89. PubMed ID: 18021238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEMS 3.0: algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins.
    Matthiesen R; Trelle MB; Højrup P; Bunkenborg J; Jensen ON
    J Proteome Res; 2005; 4(6):2338-47. PubMed ID: 16335983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phospholipase A2 activity of peroxiredoxin 6 promotes cancer cell death induced by tumor necrosis factor alpha in hepatocellular carcinoma.
    Xu X; Lu D; Zhuang R; Wei X; Xie H; Wang C; Zhu Y; Wang J; Zhong C; Zhang X; Wei Q; He Z; Zhou L; Zheng S
    Mol Carcinog; 2016 Sep; 55(9):1299-308. PubMed ID: 26293541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of peroxiredoxin 6 as a direct target of withangulatin A by quantitative chemical proteomics in non-small cell lung cancer.
    Chen C; Gong L; Liu X; Zhu T; Zhou W; Kong L; Luo J
    Redox Biol; 2021 Oct; 46():102130. PubMed ID: 34517184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic Analysis of Hippocampus in a Mouse Model of Depression Reveals Neuroprotective Function of Ubiquitin C-terminal Hydrolase L1 (UCH-L1) via Stress-induced Cysteine Oxidative Modifications.
    Choi JE; Lee JJ; Kang W; Kim HJ; Cho JH; Han PL; Lee KJ
    Mol Cell Proteomics; 2018 Sep; 17(9):1803-1823. PubMed ID: 29959188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis.
    Rolfs F; Huber M; Gruber F; Böhm F; Pfister HJ; Bochkov VN; Tschachler E; Dummer R; Hohl D; Schäfer M; Werner S
    Cancer Res; 2013 Jun; 73(11):3460-9. PubMed ID: 23576553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of post-translational modifications by blind search of mass spectra.
    Tsur D; Tanner S; Zandi E; Bafna V; Pevzner PA
    Nat Biotechnol; 2005 Dec; 23(12):1562-7. PubMed ID: 16311586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung tumor growth-promoting function of peroxiredoxin 6.
    Jo M; Yun HM; Park KR; Hee Park M; Myoung Kim T; Ho Pak J; Jae Lee S; Moon DC; Park CW; Song S; Lee CK; Bae Han S; Tae Hong J
    Free Radic Biol Med; 2013 Aug; 61():453-63. PubMed ID: 23643677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging mass spectrometry-based technologies for analyses of chromatin changes: analysis of histones and histone modifications.
    Shah B; Kozlowski RL; Han J; Borchers CH
    Methods Mol Biol; 2011; 773():259-303. PubMed ID: 21898261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and quantification of protein posttranslational modifications.
    Farley AR; Link AJ
    Methods Enzymol; 2009; 463():725-63. PubMed ID: 19892200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic profiling of acute cardiac allograft rejection.
    Kienzl K; Sarg B; Golderer G; Obrist P; Werner ER; Werner-Felmayer G; Lindner H; Maglione M; Schneeberger S; Margreiter R; Brandacher G
    Transplantation; 2009 Aug; 88(4):553-60. PubMed ID: 19696639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics: bases for protein complexity understanding.
    Rotilio D; Della Corte A; D'Imperio M; Coletta W; Marcone S; Silvestri C; Giordano L; Di Michele M; Donati MB
    Thromb Res; 2012 Mar; 129(3):257-62. PubMed ID: 22283976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
    Cuomo A; Moretti S; Minucci S; Bonaldi T
    Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics analysis of a Saccharomyces cerevisiae N-terminal proteome provides evidence of alternative translation initiation and post-translational N-terminal acetylation.
    Helsens K; Van Damme P; Degroeve S; Martens L; Arnesen T; Vandekerckhove J; Gevaert K
    J Proteome Res; 2011 Aug; 10(8):3578-89. PubMed ID: 21619078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities.
    Yun HM; Park KR; Lee HP; Lee DH; Jo M; Shin DH; Yoon DY; Han SB; Hong JT
    Free Radic Biol Med; 2014 Apr; 69():367-76. PubMed ID: 24512906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: significance of genetic background for assessing atherosclerosis.
    Wang X; Phelan SA; Petros C; Taylor EF; Ledinski G; Jürgens G; Forsman-Semb K; Paigen B
    Atherosclerosis; 2004 Nov; 177(1):61-70. PubMed ID: 15488866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of root plasma membrane aquaporins from Brassica oleracea: post-translational modifications, de novo sequencing and detection of isoforms by high resolution mass spectrometry.
    Casado-Vela J; Muries B; Carvajal M; Iloro I; Elortza F; Martínez-Ballesta MC
    J Proteome Res; 2010 Jul; 9(7):3479-94. PubMed ID: 20462273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.